While sRAGE association with microbleeds has not been examined in the CKD population, sRAGE levels are 2.4-fold higher in patients with advanced CKD, and the pro-inflammatory RAGE ligand S100A12 is fourfold higher as compared to non-CKD controls [119]. Here, S100A12 is linked to chronic kidney disease.